Order results by:
Issue | Title | |
Vol 5, No 3 (2009) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
S. N. Tereshchenko, N. A. Dzhaiani | ||
"... The role of ACE inhibitors in modern pharmacotherapy of patients with chronic heart failure (CHF ..." | ||
Vol 4, No 3 (2008) | ANGIOTENSIN II AND MYOCARDIAL INFARCTION | Abstract similar documents |
O. P. Shevchenko, А. О. Shevchenko | ||
"... disease including patients after MI ACE inhibitors reduce mortality, risk of repeated MI as well ..." | ||
Vol 5, No 2 (2009) | CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL | Abstract similar documents |
D. A. Napalkov, E. N. Golovenko | ||
"... There is grate interest to ACE inhibitors which have cardioprotective and neproprotective effects ..." | ||
Vol 6, No 1 (2010) | SOME ASPECTS OF THE LISINOPRIL USAGE IN ARTERIAL HYPERTENSION TREATMENT | Abstract similar documents |
N. A. Jaiani | ||
"... Рассматриваются обоснования и преимущества применения ингибитора АПФ лизиноприла в практической ..." | ||
Vol 10, No 5 (2014) | CHOICE OF LISINOPRIL FOR TREATMENT OF HYPERTENSION IN PATIENTS WITH CONCOMITANT DISEASES | Abstract similar documents |
N. A. Dzhaiani | ||
"... Rationale and benefits of the use of the ACE inhibitor lisinopril in the clinical practice ..." | ||
Vol 5, No 1 (2009) | ACE INHIBITORS IN ARTERIAL HYPERTENSION TREATMENT: FOCUS ON LISINOPRIL | Abstract similar documents |
V. I. Podzolkov, K. K. Osadchy | ||
"... action and advantages over other ACE inhibitors are presented. ..." | ||
Vol 9, No 2 (2013) | FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE | Abstract similar documents |
O. D. Ostroumova, I. I. Kopchenov | ||
"... converting enzyme (ACE) inhibitor and dihydropyridine calcium antagonist are considered. Data on the efficacy ..." | ||
Vol 3, No 1 (2007) | THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION | Abstract similar documents |
D. B. Nebieridze, A. S. Safaryan | ||
"... enzyme (ACE) inhibitors in clinical practice were represented. The traditional usage of emACE/em eminhibitors/em ..." | ||
Vol 5, No 4 (2009) | TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS | Abstract similar documents |
L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky | ||
"... Angiotensin converting enzyme (emACE/em) eminhibitors/em and angiotensin II receptor blockers (ARB) slow ..." | ||
Vol 4, No 2 (2008) | ACE INHIBITORS ARE RATIONAL PHARMACOTHERAPY OF ENDOTHELIAL DYSFUNCTION | Abstract similar documents |
M. P. Metrova, A. B. Salmina, A. I. Inzhutova, O. S. Bahmeteva | ||
"... Aim. To study effects of emACE/em eminhibitor/em perindopril on markers of endothelial dysfunction ..." | ||
Vol 6, No 5 (2010) | THE USE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AFTER MYOCARDIAL INFARCTION. WHAT DO EVIDENCE-BASED MEDICINE DATA SPEAK FOR? | Abstract similar documents |
S. Yu. Martsevich | ||
"... The main trails proven angiotensin converting enzyme (emACE/em) eminhibitor/em effects on the life prognosis ..." | ||
Vol 3, No 2 (2007) | RESULTS OF OUTPATIENT PROGRAM ON EFFECTIVE THERAPY OF REFRACTORY ARTERIAL HYPERTENSION | Abstract similar documents |
M. M. Batyushin, I. V. Derevyankina, M. Z. Gasanov, O. V. Akopova, K. I. Babiyan, Y. N. Boychenko, N. V. Vasilchenko, T. A. Gabysyan, S. Ch. Gayboryan, I. S. Golovatenko, N. M. Demkova, D. O. Dmitriev, E. V. Kirtava, O. L. Kotyankova, G. V. Ludanova, S. A. Lyashenko, A. E. Malichina, O. I. Poroshenko, A. V. Svechnikova, I. Y. Sidorov, E. V. Solyannikova, I. D. Tascheyan, E. A. Heygetyan, S. E. Evruyan | ||
"... converting enzyme (emACE/em) eminhibitor/em, thiazid diuretic (indapamide) and dihydropyridine calcium antagonist ..." | ||
Vol 3, No 3 (2007) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE? | Abstract similar documents |
S. Y. Martsevich, S. N. Tolpygina | ||
"... Data of studies devoted to application of angiotensin converting enzyme (emACE/em) eminhibitors/em in acute ..." | ||
Vol 8, No 4 (2012) | EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS | Abstract similar documents |
I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze | ||
"... and, first of all beta-blockers, emACE/em eminhibitors/em, diuretics, and statins on bone are presented. Mode of action ..." | ||
Vol 4, No 3 (2008) | COMPARATIVE EFFICACY OF ACE INHIBITORS (RAMIPRIL VS ENALAPRIL) IN TREATMENT OF CHRONIC HEART FAILURE IN WOMEN | Abstract similar documents |
S. N. Tereshchenko, I. V. Zhirov, E. V. Malichenko, E. E. Kazantseva | ||
Vol 1, No 1 (2005) | ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIES | Abstract similar documents |
S. A. Shalnova, S. Y. Martsevich, A. D. Deev, N. P. Kutishenko, P. G. Oganov, A. N. Britov, E. G. Volkova, K. I. Ivanov, A. M. Kalinina, L. I. Katelnitskaya, G. D. Kobalava, E. V. Kokurina, A. O. Conradi, S. K. Kukushkin, Yu. M. Lopatin, N. I. Maksimov, V. Y. Mareev, I. S. Petelin, D. V. Nebieridze, G. I. Nechayev, L. A. Sokolova, A. V. Suslikov, I. G. Fomina, A. V. Shabalin, V. A. Shulman, V. V. Yakusevich, S. S. Jakushin | ||
"... antihypertensive therapy based on emACE/em-eminhibitor/em spirapril, the second one (control group) continued their usual ..." | ||
Vol 1, No 1 (2005) | ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES | Abstract similar documents |
Y. A. Karpov | ||
"... of the role of emACE/em eminhibitors/em in treatment of patients with stable form of ischemic heart disease without ..." | ||
Vol 9, No 4 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT | Abstract similar documents |
S. Yu. Martsevich | ||
"... The results of the main large controlled trials that had proven effect of emACE/em eminhibitors/em (ACEi ..." | ||
Vol 6, No 4 (2010) | ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? | Abstract similar documents |
D. V. Nebieridze, A. S. Safarian | ||
"... New possibilities of emACE/em eminhibitors/em application on the base of international trails review ..." | ||
Vol 6, No 1 (2010) | COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION | Abstract similar documents |
S. A. Boitsov, R. M. Linchak | ||
"... attention is paid to usage of emACE/em eminhibitor/em and calcium antagonist combination. ..." | ||
Vol 13, No 2 (2017) | SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova | ||
Vol 2, No 4 (2006) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS: DECREASE IN HEART REMODELING AND IMPROVEMENT IN FUNCTION OF ENDOTHELIUM IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
K. Yu. Nikolaev, G. I. Lifshits, A. A. Nikolaeva, I. M. Gicheva | ||
"... Aim. To estimate an effect of enalapril, angiotensin converting enzyme (emACE/em) eminhibitor/em , on left ..." | ||
Vol 6, No 1 (2010) | ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES | Abstract similar documents |
E. M. Khurs, A. V. Poddubnaya | ||
"... Aim. To evaluate the cardioprotective effects of emACE/em eminhibitor/em, ramipril and angiotensin II ..." | ||
Vol 3, No 3 (2007) | REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS | Abstract similar documents |
M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova | ||
"... of antihypertensive drugs in mono- and combined therapy. Angiotensin converting enzyme (emACE/em) eminhibitors/em keep important ..." | ||
Vol 5, No 3 (2009) | FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY | Abstract similar documents |
O. G. Zaylobidinov, Yu. N. Ziyaev, N. K. Kamilova, A. S. Khalilov, B. F. Mukhamedova | ||
Vol 2, No 4 (2006) | POSTMENOPAUSAL METABOLIC SYNDROME: CORRECTION OF AUTONOMIC NERVOUS SYSTEM DISBALANCE WITH COMBINATION OF ACE-INHIBITOR AND STATIN | Abstract similar documents |
I. V. Logacheva, E. N. Shustova, E. V. Kulinich | ||
"... (emACE/em eminhibitor/em and statin), not only have antihypertensive and hypolipidemic action, but also reduce ..." | ||
Vol 4, No 1 (2008) | COMPARISON OF ACE INHIBITOR (FOSINOPRIL) AND Β-ADRENOBLOCKER (ATENOLOL) EFFECTS ON AUTONOMIC REGULATION OF THE HEART IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
A. R. Kiselyov, V. I. Gridnev, O. V. Shevchenko, O. M. Posnenkova, A. N. Strunina, V. A. Schwarz, Ja. P. Dovgalevsky | ||
Vol 9, No 5 (2013) | TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2) | Abstract similar documents |
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
"... - by 70%, emACE/em eminhibitors/em - by 60% (p0.0001). These medications prescription frequency decreased by 15-20 ..." | ||
Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
"... .3%, statins – up to 45.6%. Despite of no changes registered in prescription rate of the emACE/em eminhibitors/em, marked ..." | ||
Vol 4, No 4 (2008) | PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY | Abstract similar documents |
S. A. Boytsov, I. P. Kolos | ||
Vol 1, No 3 (2005) | COMPARATIVE ASSESSMENT OF EFFECT OF COMBINED DRUGS OF ACE INHIBITOR AND DIURETIC (“NOLIPREL FORTE” AND “CAPOZIDE”) ON CARDIOVASCULAR REMODELING IN HYPERTENSIVE PATIENTS | Abstract similar documents |
T. D. Kaplanov, V. V. Ivanenko, N. V. Ryasancevа, A. V. Legkiy, L. P. Anisimova, Yu. M. Lopatin | ||
"... drugs of emACE/em eminhibitor/em and diuretic, “Noliprel forte” (NF) and “Capozide” (CA), in hypertensive high ..." | ||
Vol 2, No 1 (2006) | DEGENERATIVE AORTIC STENOSIS: PATHOGENESIS AND NEW PRINCIPLES OF TREATMENT | Abstract similar documents |
O. V. Andropova, V. N. Anokhin | ||
Vol 16, No 2 (2020) | Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine | Abstract similar documents |
S. Yu. Martsevich | ||
"... The recent discussion about the dangers of using angiotensin-converting-enzyme (emACE/em) eminhibitors/em ..." | ||
Vol 9, No 1 (2013) | MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS | Abstract similar documents |
O. M. Drapkina, B. B. Gegenava | ||
Vol 4, No 1 (2008) | WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL | Abstract similar documents |
M. N. Mamedov, M. B. Stroeva | ||
"... . Results of DREAM trial are discussed. Influence of emACE/em eminhibitor/em, ramipril, on risk of diabetes onset ..." | ||
Vol 9, No 2 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: ISN'T IT TIME TO DRAW A LINE UNDER DISCUSSION ABOUT SUPERIORITY | Abstract similar documents |
S. Yu. Martsevich | ||
"... -Converting Enzyme emInhibitors/em and Angiotensin Receptor Blockers in Patients Without Heart Failure ..." | ||
Vol 1, No 1 (2005) | EXPERT CONSENSUS DOCUMENT ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CARDIOVASCULAR DISEASE | Abstract similar documents |
Jose Lopez-Sendon, Karl Swedberg, John McMurray, Juan Tamargo, Aldo P. Maggioni, Henry Dargie, Michal Tendera, Finn Waagstein, Jan Kjekshus, Philippe Lechat, Christian Torp-Pedersen | ||
"... Expert consensus document on angiotensin converting enzyme eminhibitors/em in cardiovascular disease. ..." | ||
Vol 7, No 1 (2011) | SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW | Abstract similar documents |
S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina | ||
"... A role of angiotensin-converting enzyme (emACE/em) eminhibitors/em in cardiovascular diseases treatment ..." | ||
Vol 4, No 1 (2008) | EDITORIAL COMMENTS ON THE ARTICLE OF M.N. MAMEDOV AND M.V. STROEVA “WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL” | Abstract similar documents |
статья Редакционная | ||
Vol 9, No 2 (2013) | A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE | Abstract similar documents |
G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi | ||
"... . Rosano, P. Perrone-Filardi «A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme emInhibitors/em ..." | ||
Vol 6, No 5 (2010) | NEW APPROACHES OF THE HYPERTENSION TREATMENT: FROM CHOOSING THE BEST DRUG TO CHOOSE THE OPTIMUM DRUGS COMBINATION | Abstract similar documents |
O. D. Ostroumova, E. A. Smolyarchuk, I. V. Khvorostyanaya | ||
"... are presented. The advantages of emACE/em eminhibitor/em+calcium channel blocker combination are shown in terms ..." | ||
Vol 7, No 5 (2011) | СHOICE OF ZOFENOPRIL AND HYDROCHLOROTHIAZIDE COMBINATION IN THE TREATMENT OF ARTERIAL HYPERTENSION | Abstract similar documents |
N. A. Dzhaiani | ||
"... situation with arterial hypertension. emACE/em eminhibitors/em have a special place among the antihypertensive drugs ..." | ||
Vol 8, No 6 (2012) | SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES | Abstract similar documents |
K. A. Gyamdzhyan, M. L. Maksimov | ||
"... , angiotensin converting enzyme eminhibitors/em and sartans, are compared. Data from evidence base of the both drug ..." | ||
Vol 5, No 6 (2009) | ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE | Abstract similar documents |
E. A. Ryabikhin, M. E. Mozheiko | ||
Vol 3, No 5 (2007) | CUMULATIVE CARDIO-VASCULAR RISK IN HYPERTENSIVE PATIENTS: EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS | Abstract similar documents |
L. I. Katelnitskaya, L. A. Haisheva, S. E. Glova | ||
"... emингибитора/em emангиотензинпревращающего/em фермента (иАПФ) эналаприла (Энам, Dr.Reddy’s). Материал и методы ..." | ||
Vol 14, No 6 (2018) | Angiotensin Converting Enzyme Inhibitors and the Risk of Lung Cancer – New Scientific Evidences or Another Example of “Pseudo-Evidence” Medicine? | Abstract PDF (Eng) similar documents |
S. Yu. Martsevich | ||
"... eminhibitors/em contribute to the development of lung cancer is analyzed. The author notes that the analysis ..." | ||
Vol 10, No 1 (2014) | TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS | Abstract similar documents |
A. M. Shilov, M. S. Dulaeva, A. O. Osia, A. S. Lishuta | ||
"... for the combination of an emACE/em eminhibitor/em with a dihydropyridine calcium channel blocker are reviewed. Data from ..." | ||
Vol 10, No 2 (2014) | ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION | Abstract similar documents |
N. A. Dzhaiani | ||
"... lercanidipine and angiotensin-converting enzyme eminhibitor/em enalapril. ..." | ||
Vol 17, No 1 (2021) | A Clinical Case: the Risk Factors of Acute Kidney Injury in a Cardiological Patient | Abstract similar documents |
E. A. Son, M. R. Kondratyuk, E. V. Fominykh, V. V. Fomin | ||
Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
"... compared with the group without AF. emACE/em eminhibitors/em (ACEi) were prescribed in 127 cases (27.4%), angiotensin ..." | ||
Vol 3, No 2 (2007) | OXIDATIVE STRESS AND POSSIBILITY TO CORRECT IT WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN PATIENTS WITH MYOCARDIAL INFARCTION ASSOCIATED WITH DIABETES MELLITUS TYPE 2 | Abstract similar documents |
K. S. Lexina, N. Y. Timofeeva, V. S. Zadionchenko, G. G. Shehian, K. A. Aldushina | ||
"... dysfunction and atherogenesis. There are data that angiotensin converting enzyme eminhibitor/em, zofenopril, has ..." | ||
Vol 2, No 4 (2006) | FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS | Abstract similar documents |
Yu. M. Lopatin | ||
"... enzyme eminhibitor/em (iACE) ramipril improves the prognosis in high risk cardio-vascular patients ..." | ||
Vol 3, No 4 (2007) | RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION | Abstract similar documents |
I. V. Szirov, E. V. Malichenko | ||
"... Angiotensin converting enzyme eminhibitors/em are the first line medicine for the treatment of the most ..." | ||
Vol 5, No 6 (2009) | ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS WITH AMLODIDINE: ORIGINAL DRUG VERSUS GENERIC | Abstract similar documents |
S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, L. A. Sokolova, V. V. Jakusevich, J. V. Lukina, M. A. Maximova, A. V. Zaharova, A. A. Serazhim, V. P. Voronina | ||
"... of emACE/em eminhibitor/em and diuretic was performed each 2 weeks. Results. The significant antihypertensive ..." | ||
Vol 2, No 1 (2006) | THE DAILY PROFILE OF BLOOD PRESSURE IN METABOLIC SYNDROME: COMPARABLE ANALYSIS OF THE EFFICACY OF MONOTHERAPY WITH ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY | Abstract similar documents |
M. N. Mamedov, V. M. Gorbunov, T. Sh. Dzahangirov | ||
"... Aim. To assess an influence of emACE/em eminhibitor/em enalapril on daily profile of blood pressure (BP ..." | ||
Vol 13, No 2 (2017) | PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA) | Abstract similar documents |
M. M. Loukianov, A. N. Kozminsky, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, A. V. Zagrebelnyy, R. P. Myasnikov, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Andreenko, E. N. Belova, A. D. Deev, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov | ||
"... converting enzyme eminhibitors/em (ACEI)/angiotensin receptor blockers (ARB) and β-blockers in the outpatient ..." | ||
Vol 9, No 2 (2013) | TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) | Abstract similar documents |
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
"... of cardiovascular complications (antiplatelets, β-blockers, emACE/em eminhibitors/em, statins) were not often prescribed ..." | ||
Vol 4, No 5 (2008) | EFFECTS OF BETAHISTINE DIHYDROCHLORIDE AS ADJUVANT TO ENALAPRIL THERAPY OF PATIENTS WITH CHRONIC HEART FAILURE CLASS II-II (NYHA) SUFFERING FROM GIDDINESS | Abstract similar documents |
S. Y. Martsevich, J. V. Lukina, V. V. Yakusevich, D. A. Anichkov, A. D. Deev, O. V. Lerman, S. N. Tolpygina, N. A. Dmitrieva, A. A. Serazhim, M. A. Maksimova, V. P. Voronina, E. V. Shilova, G. F. Andreeva, A. V. Zaharova, I. V. Novikov, А. А. Platonova, Т. А. Kazakovtseva, T. V. Babkova, L. P. Volhonskaya | ||
"... Aim. To study adjuvant effect of betahistine dihydrochloride to emACE/em eminhibitors/em in patients ..." | ||
Vol 3, No 5 (2007) | EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION | Abstract similar documents |
L. N. Chikhireva, V. I. Malahov, E. S. Bykova, S. F. Sokolov | ||
"... Aim. To evaluate effects of angiotensin converting enzyme eminhibitor/em spirapril on efficacy ..." | ||
Vol 6, No 5 (2010) | FIXED LOW-DOSE COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE IN THE PREVENTION OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS | Abstract similar documents |
A. O. Shevchenko, O. P. Shevchenko | ||
"... and hydrochlorothiazide are discussed. Reasonability of emACE/em eminhibitor/em and thiazide diuretic combination is supported due ..." | ||
Vol 8, No 1 (2012) | BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE | Abstract similar documents |
M. V. Leonova | ||
"... channel blockers, emACE/em eminhibitors/em) is evaluated. Special considerations of beta-blockers use ..." | ||
Vol 20, No 5 (2024) | Association between renin-angiotensin system gene polymorphism and cardio-ankle vascular index in patients with COVID-19 | Abstract similar documents |
V. I. Podzolkov, A. E. Bragina, E. S. Ogibenina, I. I. Shvedov, A. R. Komelkova | ||
"... -converting enzyme type 1 gene (emACE/em1), rs5186 of angiotensin II type 1 receptor gene (ATP1), and rs1403543 ..." | ||
Vol 4, No 3 (2008) | HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA | Abstract similar documents |
A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova | ||
"... 2 (D2) and chronic heart failure (CHF) treated with angiotensin converting enzyme (emACE/em) eminhibitors/em ..." | ||
Vol 6, No 4 (2010) | COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER THE STROKE | Abstract similar documents |
O. A. Ageenkova, V. A. Milyagin, N. Yu. Hozyainova | ||
"... Aim. To evaluate influence of the combined therapy with emACE/em eminhibitor/em (perindopril), diuretic ..." | ||
Vol 8, No 5 (2012) | THE LIS STUDY (LYUBERTSY STUDY OF MORTALITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION). EVALUATION OF THE PHARMACOTHERAPY. PART 1. TREATMENT OF PATIENTS BEFORE MYOCARDIAL INFARCTION AND ITS INFLUENCE ON HOSPITAL MORTALITY RATE | Abstract similar documents |
S. Y. Marcevich, M. L. Ginzburg, N. P. Kutishenko, A. D. Deev, V. P. Smirnov, L. Y. Drozdova, E. V. Danijel's, A. V. Fokina | ||
"... -blockers, 35.3% — emACE/em eminhibitors/em, 15.7% — antiplatelet drugs, 1.9% — statins. Reduction in the hospital ..." | ||
Vol 14, No 1 (2018) | COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 | Abstract similar documents |
O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman | ||
"... .05) increased. In 2014-2015 the frequency of the prescriptions of emACE/em eminhibitors/em decreased (77.8 vs 86.5%; p0 ..." | ||
Vol 7, No 5 (2011) | THE ADHERENCE TO RECOMMENDED THERAPY IN PATIENTS AFTER ACUTE CORONARY SYNDROME, AND RISK OF CARDIOVASCULAR COMPLICATIONS WITHIN A YEAR AFTER HOSPITAL ADMISSION | Abstract similar documents |
N. F. Puchin'yan, Ya. P. Dovgalevskiy, P. V. Dolotovskaya, N. V. Furman | ||
"... . Complex therapy (acetylsalicylic acid (ASA), beta-blockers (BB), emACE/em eminhibitors/em, statins) was prescribed ..." | ||
Vol 1, No 2 (2005) | ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
M. V. Leonova, M. A. Demidova, A. V. Tarasov, Y. V. Belousov | ||
"... converting enzyme (emACE/em) eminhibitor/em spirapril in patients with arterial hypertension (AH). Material ..." | ||
Vol 7, No 1 (2011) | NEW ANTIPLATELET DRUGS (PART 1) | Abstract similar documents |
A. B. Sumarokov | ||
"... antiplatelet drugs are on their way to clinical application — prasugrel, ticagrelor, elinogrel, eminhibitors/em ..." | ||
Vol 9, No 2 (2013) | ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES | Abstract similar documents |
Z. M. Safiullina, S. V. Shalaev | ||
"... Studies data on new anticoagulants, direct oral thrombin eminhibitor/em (dabigatran) and direct ..." | ||
Vol 6, No 4 (2010) | LISINOPRIL IMPLICATION IN THE CLINICAL PRACTICE | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova | ||
"... that block RAAS were emACE/em eminhibitors/em. Lisinopril deserves special attention among the emACE/em eminhibitors/em ..." | ||
Vol 15, No 4 (2019) | Antihypertensive Drug Utilization in Two Districts of Northern Cyprus | Abstract PDF (Eng) similar documents |
M. Tamirci, R. Demirdamar | ||
"... eminhibitor/em (emACE/em) eminhibitors/em (17.7%), diuretics (13.8%) and anti-adrenergic drugs (3.9%) were prescribed ..." | ||
Vol 11, No 3 (2015) | THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova | ||
"... pathogenic mechanisms of hypertension. The combination of an emACE/em eminhibitor/em and a dihydropyridine calcium ..." | ||
Vol 11, No 2 (2015) | THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS | Abstract similar documents |
E. EL. Trisvetova | ||
"... and long-lasting action. Lercanidipine had shown both in monotherapy and in combination with emACE/em eminhibitors/em ..." | ||
Vol 14, No 6 (2018) | Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation | Abstract PDF (Eng) similar documents |
A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee | ||
"... supplying beneficiaries. Diuretics, as well as some emACE/em eminhibitors/em, are not available in a number ..." | ||
Vol 7, No 5 (2011) | NEW ANTIPLATELET DRUGS. PART 2 | Abstract similar documents |
A. B. Sumarokov | ||
"... are on their way to clinical application — prasugrel, ticagrelor , elinogrel, thromboxane receptor eminhibitors/em ..." | ||
Vol 6, No 6 (2010) | NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION | Abstract similar documents |
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya | ||
"... .23. Patients were randomized into 4 treatment groups: Group A1 (angiotensin converting enzyme (emACE/em) eminhibitors/em ..." | ||
Vol 19, No 1 (2023) | Analysis of The Use of PCSK9 Inhibitors in Clinical Practice | Abstract similar documents |
S. Yu. Volkova, L. A. Boyarskaya, P. Yu. Toropygin, I. A. Morozov, E. A. Boyarskaya | ||
"... Aim. The analysis of the experience of using PCSK9 eminhibitors/em (alirocumab) in patients with very ..." | ||
Vol 19, No 6 (2023) | Acute kidney injury as a risk factor for atrial fibrillation after coronary artery bypass grafting — effects of sodium-glucose cotransporter-2 inhibitors | Abstract similar documents |
L. V. Kremneva, L. A. Arutyunyan, L. I. Gapon, S. N. Suplotov, S. V. Shalaev | ||
"... cotransporter 2 (SGLT-2) eminhibitors/em. Material and methods. We examined 92 patients with stable angina who ..." | ||
Vol 8, No 6 (2012) | THE LIS STUDY (LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION). EVALUATION OF DRUG THERAPY. PART 2. INFLUENCE OF PREVIOUS DRUG TREATMENT ON LONG-TERM LIFE PROGNOSIS | Abstract similar documents |
S. Yu. Martsevich, M. L. Gynzburg, N. P. Kutishenko, A. D. Deev, V. P. Smirnov, L. U. Drozdova, E. V. Daniels, A. V. Fokina | ||
"... -blockers, emACE/em eminhibitors/em, statins), at that emACE/em eminhibitors/em were prescribed more often than the others. Use ..." | ||
Vol 10, No 6 (2014) | СONCOMITANT ADMINISTRATION OF CLOPIDOGREL AND PROTON PUMP INHIBITORS: ARE THERE ANY OPEN QUESTIONS LEFT TODAY? | Abstract similar documents |
S. Yu. Martsevich, A. Yu. Suvorov | ||
"... Concomitant administration of clopidogrel and proton pump eminhibitors/em (PPI), the possible influence ..." | ||
Vol 17, No 2 (2021) | Management of Patients with Chronic Heart Failure and Diabetes Mellitus | Abstract similar documents |
E. V. Reznik, T. L. Nguyen, G. N. Golukhov | ||
"... of the prescribed drugs. Angiotensin receptor-neprilysin eminhibitor/em are increasingly used in clinical practice ..." | ||
Vol 5, No 2 (2009) | EFFECT OF ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
G. F. Andreeva, A. D. Deev, V. M. Gorbunov | ||
"... not affect QoL. emACE/em eminhibitors/em similarly improved QoL. Conclusion. Antihypertensive drugs (diltiazem ..." | ||
Vol 8, No 2 (2012) | RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS | Abstract similar documents |
A. A. Lomonosova, N. A. Mazur, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva, N. V. Shestakova | ||
Vol 20, No 2 (2024) | Cardiotoxicity mechanisms of antitumor therapy with immune checkpoint inhibitors: new achievements | Abstract similar documents |
L. D. Khidirova, A. E. Latsvieva, A. V. Vederin | ||
"... The immune checkpoint eminhibitors/em (ICTs) emergence has opened up new perspectives in cancer ..." | ||
Vol 12, No 3 (2016) | GENETIC PREDICTORS OF ATRIAL FIBRILLATION | Abstract PDF (Eng) similar documents |
A. V. Kuskaeva, S. Yu. Nikulina, A. A. Chernova, N. V. Aksyutina | ||
"... are of great practical interest, as associative effect of angiotensin-converting enzyme eminhibitors/em ..." | ||
Vol 15, No 4 (2019) | The Study of the Fixed Dose Combination of Lisinopril with Prolonged Indopamide (FIXLINDA) with Daily Blood Pressure Monitoring and Diuresis in Hypertensive Patients | Abstract similar documents |
M. P. Savenkov, S. N. Ivanov, M. P. Mikhaylusova, M. V. Borschevskaya, A. M. Savenkova, N. Y. Kozachenko, E. S. Sherifova | ||
"... of treatment. Conclusion. The fixed dose combination of the emACE/em eminhibitor/em lisinopril (5, 10 or 20 mg ..." | ||
Vol 6, No 5 (2010) | PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE | Abstract similar documents |
M. N. Mamedov, G. G. Sharvadze, E. A. Poddubsky, A. K. Ausheva | ||
"... . The phosphodiesterase-5 (PDE5) eminhibitors/em increase the relaxing effect of nitric oxide and increase cyclic GMP levels ..." | ||
Vol 3, No 5 (2007) | THE EFFECT OF ENALAPRIL ON THE FUNCTIONAL AND APOPTOTIC ACTIVITY OF NEUTROPHILS IN PATIENTS WITH RHEUMATIC HEART DISEASE | Abstract similar documents |
M. V. Ilyin, A. O. Khrustalev | ||
"... Цель. Изучить влияния emингибитора/em emангиотензинпревращающего/em фермента эналаприла на функциональный ..." | ||
Vol 14, No 1 (2018) | COMORBID PATIENT IN GASTROENTEROLOGY: INDIVIDUAL APPROACH | Abstract similar documents |
I. G. Bakulin, S. A. Sayganov, M. I. Skalinskaya, E. V. Skazyayeva, I. V. Lapinskii | ||
"... eminhibitors/em, depending on clinical dynamics. The rationale for the replacement of proton pump eminhibitors/em ..." | ||
Vol 16, No 4 (2020) | Evaluating Adherence to Medical Therapy in Patients with Chronic Heart Failure: Design and First Results of the COMPLIANCE Study | Abstract similar documents |
S. Yu. Martsevich, E. T. Guseynova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, S. V. Blagodatskih | ||
"... included into the study were analyzed. 90% of patients received angiotensin-converting enzyme eminhibitors/em ..." | ||
Vol 6, No 2 (2010) | RATIONAL COMBINATIONS IN HYPERTENSION TREATMENT | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova | ||
"... Influence of the combined antihypertensive therapy, including combination of emACE/em eminhibitors/em ..." | ||
Vol 16, No 4 (2020) | Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues | Abstract similar documents |
M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova | ||
"... considers the place of proprotein convertase subtilisin/kexin type 9 (PCSK9) eminhibitors/em in the prevention ..." | ||
Vol 12, No 1 (2016) | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) | Abstract PDF (Eng) similar documents |
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, N. N. Nikulina, K. G. Pereverzeva, E. A. Pravkina, A. D. Deev, E. V. Kudryashov, E. N. Belova | ||
"... was 26.1%. We have noted insufficient emACE/em eminhibitors/em/angiotensin receptor blockers (ARB) and beta ..." | ||
Vol 14, No 2 (2018) | PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS | Abstract similar documents |
S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov | ||
"... complex compared to routine therapy in patients with diabetes type 2 and emACE/em eminhibitor/em intolerance within ..." | ||
Vol 4, No 2 (2008) | RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE | Abstract similar documents |
A. I. Chesnikova, I. N. Koshenskaja, V. P. Terentyev, N. N. Mozhaeva, I. V. Bedareva, L. A. Lavrik, T. V. Zhertovsky | ||
"... as emACE/em eminhibitor/em ramipril (Hartil, EGIS). Changes in clinical status, daily BP profile, cardio-vascular ..." | ||
Vol 17, No 6 (2021) | PCSK9 Inhibitors in Clinical Practice: Experience of a Specialized Lipid Center | Abstract similar documents |
A. V. Blokhina, A. I. Ershova, A. S. Limonova, O. V. Kopylova, A. N. Meshkov, O. M. Drapkina | ||
"... Aim. To characterize patients receiving PCSK9 eminhibitors/em, and assess the efficiency ..." | ||
Vol 10, No 4 (2014) | PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE | Abstract similar documents |
E. I. Tarlovskaya, Y. A. Balandina, N. S. Maximchuk-Kolobova | ||
"... Aim. To pursue pharmacoeconomic analysis of two drug combinations of emACE/em eminhibitor/em (enalapril ..." | ||
Vol 10, No 5 (2014) | OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract PDF (Eng) similar documents |
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov | ||
"... .01, respectively). Patients treated with emACE/em eminhibitors/em or angiotensin receptor blockers (ARB) had lower all-cause ..." | ||
Vol 12, No 6 (2016) | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) | Abstract similar documents |
M. Loukianov | ||
"... was 26.1%. We have noted insufficient emACE/em eminhibitors/em/angiotensin receptor blockers (ARB) and beta ..." | ||
1 - 100 of 278 Items | 1 2 3 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)